Homebiopharmaceutical

biopharmaceutical

Sanofi’s (SNY) Dupixent Gets Europe Nod for Prurigo Nodularis

Sanofi’s (SNY) Dupixent Gets Europe Nod for Prurigo Nodularis

December 15, 2022

Cyclacel Pharmaceuticals to Present at Biotech Showcase and Participate in a Corporate Access Event During the J.P. Morgan Healthcare Conference in January 2023

Cyclacel Pharmaceuticals to Present at Biotech Showcase and Participate in a Corporate Access Event During the J.P. Morgan Healthcare Conference in January 2023

December 15, 2022

Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

December 15, 2022

aTyr Pharma Announces LTBP1 as Target of DARS tRNA Synthetase Fragment

aTyr Pharma Announces LTBP1 as Target of DARS tRNA Synthetase Fragment

December 15, 2022

Genprex Strengthens Diabetes Gene Therapy Program with License of Additional Technology from University of Pittsburgh

Genprex Strengthens Diabetes Gene Therapy Program with License of Additional Technology from University of Pittsburgh

December 15, 2022

ASLAN Pharmaceuticals Announces First Patient Screened in Study of Eblasakimab in Dupilumab Experienced Atopic Dermatitis Patients

ASLAN Pharmaceuticals Announces First Patient Screened in Study of Eblasakimab in Dupilumab Experienced Atopic Dermatitis Patients

December 15, 2022

CASI PHARMACEUTICALS’ PARTNER JUVENTAS ANNOUNCES NEW DRUG APPLICATION FOR CNCT19 ACCEPTED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION

CASI PHARMACEUTICALS’ PARTNER JUVENTAS ANNOUNCES NEW DRUG APPLICATION FOR CNCT19 ACCEPTED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION

December 15, 2022

CLASS ACTION UPDATE for EIGR, VERU and TWST: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

CLASS ACTION UPDATE for EIGR, VERU and TWST: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

December 14, 2022

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) Announces Receipt of Extension to Meet the Nasdaq’s Minimum Bid Price Requirement

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) Announces Receipt of Extension to Meet the Nasdaq’s Minimum Bid Price Requirement

December 14, 2022

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EIGR

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EIGR

December 14, 2022

« 1 … 10 11 12 13 14 … 558 »